€73.60
0.55%
Paris, Oct 02, 05:35 pm CEST. Closed.
ISIN
FR0004186856
Symbol
VETO

Vetoquinol Target price 2026 - Analyst rating & recommendation

Vetoquinol Classifications & Recommendation

Buy
70%
Hold
30%

Vetoquinol Price Target

Target Price €87.72
Price €73.60
Potential
Number of Estimates 5
5 Analysts have issued a price target Vetoquinol 2027 . The average Vetoquinol target price is €87.72. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 10 analysts: 7 Analysts recommend Vetoquinol to buy, 3 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Vetoquinol stock has an average upside potential 2027 of . Most analysts recommend the Vetoquinol stock at Purchase.

Sales and Margin forecast 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Dec '25 2026
Estimates
Revenue Million € 525.69 537.41
2.51% 2.23%
EBITDA Margin 21.10% 21.33%
4.24% 1.10%
Net Margin 10.91% 11.40%
0.25% 4.48%

6 Analysts have issued a sales forecast Vetoquinol 2026 . The average Vetoquinol sales estimate is

€537m
unlock
. This is
1.91% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
€562m 6.53%
unlock
, the lowest is
€510m 3.36%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 €526m 2.51%
2026
€537m 2.23%
unlock
2027
€559m 3.94%
unlock
2028
€584m 4.62%
unlock

6 Analysts have issued an Vetoquinol EBITDA forecast 2026. The average Vetoquinol EBITDA estimate is

€115m
unlock
. This is
0.04% lower
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
€121m 5.27%
unlock
, the lowest is
€104m 8.92%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 €111m 1.63%
2026
€115m 3.37%
unlock
2027
€121m 5.34%
unlock
2028
€128m 5.70%
unlock

EBITDA Margin

2025 21.10% 4.24%
2026
21.33% 1.10%
unlock
2027
21.62% 1.36%
unlock
2028
21.84% 1.02%
unlock

7 Vetoquinol Analysts have issued a net profit forecast 2026. The average Vetoquinol net profit estimate is

€61.2m
unlock
. This is
2.53% lower
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
€68.7m 9.34%
unlock
, the lowest is
€51.6m 17.86%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 €57.4m 2.27%
2026
€61.2m 6.76%
unlock
2027
€65.1m 6.22%
unlock
2028
€69.4m 6.72%
unlock

Net Margin

2025 10.91% 0.25%
2026
11.40% 4.48%
unlock
2027
11.64% 2.11%
unlock
2028
11.88% 2.06%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Dec '25 2026
Estimates
Earnings Per Share € 4.94 5.28
0.80% 6.88%
P/E 13.94
EV/Sales 1.20

7 Analysts have issued a Vetoquinol forecast for earnings per share. The average Vetoquinol EPS is

€5.28
unlock
. This is
2.40% lower
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
€5.92 9.43%
unlock
, the lowest is
€4.45 17.74%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 €4.94 0.80%
2026
€5.28 6.88%
unlock
2027
€5.61 6.25%
unlock
2028
€5.98 6.60%
unlock

P/E ratio

Current 13.60 10.24%
2026
13.94 2.47%
unlock
2027
13.13 5.81%
unlock
2028
12.30 6.32%
unlock

Based on analysts' sales estimates for 2026, the Vetoquinol stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 1.22 12.23%
2026
1.20 1.96%
unlock
2027
1.15 3.79%
unlock
2028
1.10 4.41%
unlock

P/S ratio

Current 1.64 3.02%
2026
1.61 1.88%
unlock
2027
1.55 3.79%
unlock
2028
1.48 4.41%
unlock

Current Vetoquinol Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
TP ICAP
Locked
➜
Locked
Locked Sep 14 2026
STIFEL EUROPE
Locked
➜
Locked
Locked Sep 11 2026
ESN/CIC MARKET SOLUTIONS
Locked
➜
Locked
Locked Sep 11 2026
ESN/CIC MARKET SOLUTIONS
Locked
➜
Locked
Locked Jun 18 2026
ESN/CIC MARKET SOLUTIONS
Locked
➜
Locked
Locked Jun 17 2026
STIFEL EUROPE
Locked
➜
Locked
Locked Mar 31 2026
STIFEL EUROPE
Locked
➜
Locked
Locked Mar 30 2026
Analyst Rating Date
Locked
TP ICAP:
Locked
➜
Locked
Sep 14 2026
Locked
STIFEL EUROPE:
Locked
➜
Locked
Sep 11 2026
Locked
ESN/CIC MARKET SOLUTIONS:
Locked
➜
Locked
Sep 11 2026
Locked
ESN/CIC MARKET SOLUTIONS:
Locked
➜
Locked
Jun 18 2026
Locked
ESN/CIC MARKET SOLUTIONS:
Locked
➜
Locked
Jun 17 2026
Locked
STIFEL EUROPE:
Locked
➜
Locked
Mar 31 2026
Locked
STIFEL EUROPE:
Locked
➜
Locked
Mar 30 2026

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today